Literature DB >> 18617497

Omeprazole and refractory hypomagnesaemia.

N Shabajee1, E J Lamb, I Sturgess, R W Sumathipala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18617497      PMCID： PMC2483862          DOI： 10.1136/bmj.39505.738981.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Alteration in digestion and absorption of nutrients during profound acid suppression.

Authors:  P Evenepoel
Journal:  Best Pract Res Clin Gastroenterol       Date:  2001-06       Impact factor: 3.043

2.  Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

Authors:  Martin Epstein; Shaun McGrath; Florence Law
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

3.  Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex.

Authors:  D Marples; J Frøkiaer; J Dørup; M A Knepper; S Nielsen
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

Review 4.  Renal magnesium handling: new insights in understanding old problems.

Authors:  G A Quamme
Journal:  Kidney Int       Date:  1997-11       Impact factor: 10.612

Review 5.  The role of magnesium in clinical biochemistry: an overview.

Authors:  M F Ryan
Journal:  Ann Clin Biochem       Date:  1991-01       Impact factor: 2.057

6.  Hypomagnesaemia: studies of parathyroid hormone secretion and function.

Authors:  J Allgrove; S Adami; L Fraher; A Reuben; J L O'Riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1984-10       Impact factor: 3.478

7.  Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.

Authors:  C Serfaty-Lacrosniere; R J Wood; D Voytko; J R Saltzman; M Pedrosa; T E Sepe; R R Russell
Journal:  J Am Coll Nutr       Date:  1995-08       Impact factor: 3.169
  7 in total
  33 in total

1.  Proton pump inhibitor associated hypomagnasaemia - a cause for concern?

Authors:  Joe Begley; Trevor Smith; Kirsty Barnett; Paul Strike; Adnan Azim; Claire Spake; Tristan Richardson
Journal:  Br J Clin Pharmacol       Date:  2016-01-25       Impact factor: 4.335

2.  Negative chronotropic effect of proton pump inhibitors on frog-heart preparation.

Authors:  Chander Shekhar Gautam; Amita Utreja; Divya Goel; Gurpreet Sandhu; Nidhi Gogia
Journal:  Indian J Gastroenterol       Date:  2009-11-24

3.  Proton pump inhibitor-induced hypomagnesemia: A new challenge.

Authors:  Matilda Florentin; Moses S Elisaf
Journal:  World J Nephrol       Date:  2012-12-06

4.  Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Guido Bonoldi
Journal:  Eur J Clin Pharmacol       Date:  2016-11-28       Impact factor: 2.953

Review 5.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 6.  Safety signal detection: the relevance of literature review.

Authors:  Helena Pontes; Mallorie Clément; Victoria Rollason
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

7.  Proton-pump inhibitor use is associated with lower urinary magnesium excretion.

Authors:  Jeffrey H William; Rachel Nelson; Najwah Hayman; Kenneth J Mukamal; John Danziger
Journal:  Nephrology (Carlton)       Date:  2014-12       Impact factor: 2.506

8.  Severe hypomagnesaemia due to lansoprazole.

Authors:  Chit Hmu; Probal Moulik; Andrew Macleod
Journal:  BMJ Case Rep       Date:  2009-12-17

9.  The inhibitory role of purinergic P2Y receptor on Mg2+ transport across intestinal epithelium-like Caco-2 monolayer.

Authors:  Narongrit Thongon; Siriporn Chamniansawat
Journal:  J Physiol Sci       Date:  2018-07-21       Impact factor: 2.781

10.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.